Wells Fargo’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.7K | Sell |
|
|||||
|
2025
Q1 | $53.2K | Buy |
|
|||||
|
2024
Q4 | $85.3K | Buy |
|
|||||
|
2024
Q3 | $48.6K | Buy |
|
|||||
|
2024
Q2 | $77.7K | Buy |
|
|||||
|
2024
Q1 | $84.2K | Buy |
|
|||||
|
2023
Q4 | $96.9K | Sell |
|
|||||
|
2023
Q3 | $682K | Buy |
|
|||||
|
2023
Q2 | $154K | Sell |
|
|||||
|
2023
Q1 | $585K | Buy |
|
|||||
|
2022
Q4 | $44.2K | Sell |
|
|||||
|
2022
Q3 | $92K | Sell |
|
|||||
|
2022
Q2 | $78K | Sell |
|
|||||
|
2022
Q1 | $512K | Sell |
|
|||||
|
2021
Q4 | $969K | Sell |
|
|||||
|
2021
Q3 | $2.26M | Sell |
|
|||||
|
2021
Q2 | $3.44M | Sell |
|
|||||
|
2021
Q1 | $3.65M | Sell |
|
|||||
|
2020
Q4 | $5.59M | Sell |
|
|||||
|
2020
Q3 | $7.39M | Buy |
|
|||||
|
2020
Q2 | $7.01M | Buy |
|
|||||
|
2020
Q1 | $6.18M | Sell |
|
|||||
|
2019
Q4 | $8.95M | Buy |
|
|||||
|
2019
Q3 | $7.97M | Buy |
|
|||||
|
2019
Q2 | $5.86M | Sell |
|
|||||
|
2019
Q1 | $3.65M | Sell |
|
|||||
|
2018
Q4 | $2.43M | Buy |
|
|||||
|
2018
Q3 | $4.36M | Buy |
|
|||||
|
2018
Q2 | $3.44M | Buy |
|
|||||
|
2018
Q1 | $2.41M | Buy |
|
|||||
|
2017
Q4 | $1.87M | Buy |
|
|||||
|
2017
Q3 | $2.06M | Buy |
|
|||||
|
2017
Q2 | $418K | Buy |
|
|||||
|
2017
Q1 | $611K | Buy |
|
|||||
|
2016
Q4 | $637K | Buy |
|
|||||
|
2016
Q3 | $358K | Buy |
|
|||||
|
2016
Q2 | $203K | Sell |
|
|||||
|
2016
Q1 | $283K | Buy |
|
|||||
|
2015
Q4 | $205K | Buy |
|
|||||
|
2015
Q3 | $95K | Sell |
|
|||||
|
2015
Q2 | $158K | Buy |
|
|||||
|
2015
Q1 | $10K | Buy |
|